Spiller, Robin; Simren, Magnus
August 2008
Gut;Aug2008, Vol. 57 Issue 8, p1027
Academic Journal
The article offers world news briefs. The numbers of colorectal cancer patients in South East Asia has doubled in the past 20 years. Chronic inflammation is a risk factor for cancer studies. Options are being studied to overcome the shortage of liver donors such as the regenerative properties of hepatic progenitor cells.


Related Articles

  • P53 Linked to Inflammation. Breindl, Anette // BioWorld Today;5/20/2013, Vol. 24 Issue 96, Special section p2 

    The article discusses a research on inflammation-associated colon cancer, in reference to a study conducted by researchers from the Israeli Weizmann Institute of Science and published in the May 13, 2013 issue of "Cancer Cell."

  • CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer. MING BAI; XIA CHEN; YI BA // Molecular & Clinical Oncology;Jan2016, Vol. 4 Issue 1, p23 

    The CXCL10/CXCR3 axis of inflammatory mediators is one of the most important groups of chemokine axes, which has been proven to be a lymphocyte-associated metastasis mediator in several tumors. The term inflammatory adhesions refers to tumors found to be attached to the surrouding tissues during...

  • Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities. Knorr, C.; Reingruber, B.; Meyer, T.; Hohenberger, W.; Stremmel, C. // International Journal of Colorectal Disease;May2004, Vol. 19 Issue 3, p181 

    Background and aims. Intraperitoneal carcinomatosis accounts for 25–35% of recurrences of colorectal cancer. Studies demonstrate that peritoneal carcinomatosis is not necessarily a terminal condition with no options for treatment or cure. Results. The combination of aggressive...

  • Laparoscopic Colectomy: The View from the United Kingdom. Bagnall, Nigel; Faiz, Omar // Journal of Gastrointestinal Surgery;Aug2013, Vol. 17 Issue 8, p1544 

    No abstract available.

  • Editorial. Danese, Silvio // Current Drug Targets;May2008, Vol. 9 Issue 5, p360 

    The author reflects on the association between inflammation and the promotion of cancer. He notes that most epidemiological research have demonstrated that chronic inflammation predisposes people to certain cancers. He states that increased expression of genes linked with macrophage infiltration...

  • The human TLR4 variant D299G mediates inflammation-associated cancer progression in the intestinal epithelium. Cario, Elke // OncoImmunology;Jul2013, Vol. 2 Issue 7, pe24890-1 

    Homeostatic TLR4 signaling protects the intestinal epithelium in health. Evidence suggests that perturbed TLR4 signaling is linked to carcinogenesis. We have recently demonstrated that the common human TLR4 variant D299G exerts pro-inflammatory efects and drives malignant tumor progression in...

  • IL6 genotypes and colon and rectal cancer. Martha Slattery; Roger Wolff; Jennifer Herrick; Bette Caan; John Potter // Cancer Causes & Control;Dec2007, Vol. 18 Issue 10, p1095 

    Abstract  Inflammation appears to play a key role in the development of colorectal cancer (CRC). In this study we examine factors involved in the regulation of inflammation and risk of CRC. Data from a multi-center case–control study of colon...

  • Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.  // BMC Cancer;2011, Vol. 11 Issue 1, p339 

    The article offers information on a research on colorectal cancer (CRC) genetic susceptibility in EPICOLON, a prospective multicenter, nationwide Spanish initiative. It states that mucins are protein constituents of mucous barrier, that are highly glycosylated by...

  • Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction. Seung-Gu Yeo; Dae Yong Kim; Tae Hyun Kim; Sun Young Kim; Yong Sang Hong; Kyung Hae Jung // Radiation Oncology;2010, Vol. 5, p97 

    Background: To investigate whether whole-liver radiotherapy (RT) is beneficial in end-stage colorectal cancer with massive liver metastases and severe hepatic dysfunction. Methods: Between June 2004 and July 2008, 10 colorectal cancer patients, who exhibited a replacement of over three quarters...

  • Discovery Could Lead to Testing That Displaces Colonoscopies.  // Clinical Lab Products;Mar2011, Vol. 41 Issue 3, p12 

    The article reports on a new method developed at the University of Missouri in Colombia, Missouri in 2011 that has potential to predict colon cancer caused by inflammation through the use of genetic biomarkers.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics